Expert biomarker bioanalysis –
from analytical strategies to data delivery.
Biomarkers are playing an ever-increasing role in discovery and development of drugs, and have a wide range of potential clinical utilities.
Resolian provides a highly accomplished team with extensive experience in biomarker development and analysis, and the skills and expertise to build you a right-fit biomarker solution.
Spanning all phases of drug development, Resolian’s personalized biomarker solutions help drive your development program to market.
Reach out to us directly to learn more about Resolian’s Biomarker services.
Resolian – the biomarker specialists.
We deliver end-to-end biomarker support – combining analytical precision with translational expertise to accelerate your program.
RT-qPCR and ddPCR for mRNA and miRNA biomarkers
Comprehensive flow cytometry capabilities for quantitative and qualitative biomarker assessment
Oligonucleotide based protein biomarkers
(PCSK9, AGT, SOD1, Activin E, ALK7, GRB14, etc)
Ready to use in-house established methods for common targets including cytokines
End-to-end support: from Context of Use assay development to regulatory-ready data packages
Strategic partners, not just a lab – we help design your entire biomarker analytical strategy
Flexible platforms tailored to your molecule and regulatory needs
Global network of bioanalytical labs with deep submission experience
Assessing new technologies and approaches
Scientists embedded in key industry forums – ensuring methods reflect the latest regulatory thinking
Immunoassay:
Chromatography:
Our Fordham site is Certified Service Provider Status on Ella™ Platform
Our Fordham and Malvern sites are both a Gyrolab Certified CRO Partner.
Partner with the global biomarker specialist that delivers scientific excellence, regulatory expertise, and seamless project management.
Copyright © 2026 Resolian Inc. All rights reserved.